Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg disease

Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg disease

US Patent 11185554 · Granted Nov 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pan-ebola virus neutralizing human antibodies and methods of use therefor2024
Antibody-mediated neutralization of Marburg virus2021
Antibody-mediated neutralization of ebolaviruses2021
Antibody-mediated neutralization of Ebola viruses2020
Antibody-mediated neutralization of Marburg virus2019
Inhibitors of protein phosphatase-1 and uses thereof2016
Deazapurines and uses thereof2014
Benzoxazole compounds and methods of use2013
Macrocyclic compounds useful as pharmaceuticals2012
Macrocyclic compounds useful as pharmaceuticals2011
Deazapurines and uses thereof2011
Macrocyclic compounds useful as pharmaceuticals2010